Загрузка...
AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
Biomarkers for predicting the risk of castration-resistant prostate cancer (CRPC) in men treated with primary androgen deprivation therapy (ADT) are lacking. We investigated whether Zinc-alpha 2 glycoprotein (AZGP1) expression in the diagnostic biopsies of men with hormone-naïve prostate cancer (PCa...
Сохранить в:
| Опубликовано в: : | Diagnostics (Basel) |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7460336/ https://ncbi.nlm.nih.gov/pubmed/32726925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10080520 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|